Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,785 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma.
Kumar A, Casulo C, Yahalom J, Schöder H, Barr PM, Caron P, Chiu A, Constine LS, Drullinsky P, Friedberg JW, Gerecitano JF, Hamilton A, Hamlin PA, Horwitz SM, Jacob AG, Matasar MJ, McArthur GN, McCall SJ, Moskowitz AJ, Noy A, Palomba ML, Portlock CS, Straus DJ, VanderEls N, Verwys SL, Yang J, Younes A, Zelenetz AD, Zhang Z, Moskowitz CH. Kumar A, et al. Blood. 2016 Sep 15;128(11):1458-64. doi: 10.1182/blood-2016-03-703470. Epub 2016 Jul 25. Blood. 2016. PMID: 27458003 Free PMC article.
Deauville Dubiosity.
Yang JC, Yahalom J. Yang JC, et al. Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):16. doi: 10.1016/j.ijrobp.2018.09.032. Int J Radiat Oncol Biol Phys. 2020. PMID: 31836078 No abstract available.
ILROG Lymphoma Mini-Atlas Part II, Hodgkin Lymphoma.
Dabaja BS, Ng AK, Terezakis SA, Plastaras JP, Yunes M, Wilson LD, Yang J, Gunther JR, Specht L, Yahalom J. Dabaja BS, et al. Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):977-978. doi: 10.1016/j.ijrobp.2020.05.063. Epub 2020 Aug 4. Int J Radiat Oncol Biol Phys. 2020. PMID: 32768256 No abstract available.
Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma.
Kumar A, Casulo C, Advani RH, Budde E, Barr PM, Batlevi CL, Caron P, Constine LS, Dandapani SV, Drill E, Drullinsky P, Friedberg JW, Grieve C, Hamilton A, Hamlin PA, Hoppe RT, Horwitz SM, Joseph A, Khan N, Laraque L, Matasar MJ, Moskowitz AJ, Noy A, Palomba ML, Schöder H, Straus DJ, Vemuri S, Yang J, Younes A, Zelenetz AD, Yahalom J, Moskowitz CH. Kumar A, et al. J Clin Oncol. 2021 Jul 10;39(20):2257-2265. doi: 10.1200/JCO.21.00108. Epub 2021 Apr 28. J Clin Oncol. 2021. PMID: 33909449
Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?
Imber BS, Chau KW, Lee J, Lee J, Casey DL, Yang JC, Wijentunga NA, Shepherd A, Hajj C, Qi S, Chelius MR, Hamlin PA, Palomba ML, Joffe E, Zhang Z, Zelenetz AD, Salles GA, Yahalom J. Imber BS, et al. Among authors: yang jc. Blood Adv. 2021 Oct 26;5(20):4185-4197. doi: 10.1182/bloodadvances.2021004939. Blood Adv. 2021. PMID: 34529789 Free PMC article.
1,785 results